Repare Therapeutics Inc. financial data

Symbol
RPTX on Nasdaq
Location
Saint Laurent, Quebec, Canada
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 741% % 5.6%
Debt-to-equity 15% % -8.4%
Return On Equity -58% % -41%
Return On Assets -50% % -43%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42,985,755 shares 1.1%
Common Stock, Shares, Outstanding 42,985,755 shares 1.1%
Entity Public Float $128,954,706 USD -66%
Common Stock, Value, Issued $490,487,000 USD 0.78%
Weighted Average Number of Shares Outstanding, Basic 42,965,529 shares 1.2%
Weighted Average Number of Shares Outstanding, Diluted 43,051,934 shares 1.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $66,550,000 USD -47%
General and Administrative Expense $24,530,000 USD -23%
Operating Income (Loss) $78,484,000 USD 16%
Nonoperating Income (Expense) $7,047,000 USD -38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $71,437,000 USD 13%
Income Tax Expense (Benefit) $763,000 USD -53%
Net Income (Loss) Attributable to Parent $72,200,000 USD 14%
Earnings Per Share, Basic -1 USD/shares 15%
Earnings Per Share, Diluted -1 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $72,825,000 USD -9.6%
Marketable Securities, Current $39,779,000 USD -60%
Assets, Current $124,426,000 USD -38%
Property, Plant and Equipment, Net $0 USD -100%
Operating Lease, Right-of-Use Asset $0 USD -100%
Other Assets, Noncurrent $600,000 USD 235%
Assets $126,747,000 USD -39%
Accounts Payable, Current $1,334,000 USD -87%
Employee-related Liabilities, Current $2,353,000 USD -53%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $11,620,000 USD -63%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $11,620,000 USD -63%
Accumulated Other Comprehensive Income (Loss), Net of Tax $14,000 USD -90%
Retained Earnings (Accumulated Deficit) $461,327,000 USD -19%
Stockholders' Equity Attributable to Parent $115,127,000 USD -34%
Liabilities and Equity $126,747,000 USD -39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $29,133,000 USD -344%
Net Cash Provided by (Used in) Financing Activities $79,000 USD -79%
Net Cash Provided by (Used in) Investing Activities $28,792,000 USD
Common Stock, Shares, Issued 42,985,755 shares 1.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $262,000 USD 97%
Deferred Tax Assets, Valuation Allowance $139,757,000 USD 25%
Deferred Tax Assets, Gross $139,757,000 USD 25%
Operating Lease, Liability $1,933,000 USD -43%
Depreciation $1,186,000 USD 137%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $72,326,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid $2,001,000 USD -43%
Property, Plant and Equipment, Gross $11,498,000 USD -0.18%
Operating Lease, Liability, Current $342,000 USD -85%
Lessee, Operating Lease, Liability, to be Paid, Year Two $88,000 USD -91%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,913,000 USD -23%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 39%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $68,000 USD -33%
Deferred Tax Assets, Operating Loss Carryforwards $92,678,000 USD 33%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits $0 USD
Operating Lease, Payments $590,000 USD -3.8%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $12,324,000 USD -50%